Latest Commercialisation News

Altech Batteries has refreshed its board and launched a strategic reset aimed at accelerating the commercial rollout of its advanced CERENERGY and Silumina Anodes™ battery technologies.

HITIQ Limited is set to introduce its PROTEQT™ concussion management system through rebel, Australia's largest sporting goods retailer, marking a strategic entry into mainstream consumer retail channels starting January 2026.

Urenco Limited has secured Foreign Investment Review Board approval for its strategic investment in Ubaryon, where Global Uranium and Enrichment Limited holds a significant stake, marking a key milestone in advancing innovative uranium enrichment technology.

Admiralty Resources has secured a pivotal contract with global trader Trafigura to market its Mariposa Iron Ore, marking a key step towards commercial production and revenue generation.

Firebird Metals has secured a key patent for its energy-efficient kiln and announced plans for an Australian Demonstration Plant to commercialise its battery materials technology.

Metallium Ltd has revealed significant progress in commercialising its Flash Joule Heating technology with a new Texas facility and key partnerships, setting the stage for global expansion in critical metals recovery.

Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Reward Minerals has secured 100% ownership of the Copper Lance Project in Newfoundland, initiating field sampling to validate historic high-grade copper, silver, and gold mineralisation. The project reveals multiple undrilled anomalies and new exploration targets in a prolific VMS district.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

Altech Batteries has completed the final design of its next-generation Sodium Nickel Chloride UPS battery system, setting the stage for factory testing and trial deployments across the Netherlands. This milestone marks a significant step toward broader European commercialisation.

ReNerve Ltd reports a strong 53% year-on-year revenue increase, expanding its US distribution network and advancing clinical studies for its nerve repair products. The company is poised for significant global market growth with new partnerships and upcoming product launches.